Difference between revisions of "Fallon Currie Consulting"
(→Reassuring the public about the safety of aspartame) |
(→Reassuring the public about the safety of aspartame) |
||
| Line 5: | Line 5: | ||
In 2000 it set up a website, [[Aspartame Information]] (http://www.aspartame-info.com), to give information to the public about the controversial artificial sweetener [[aspartame]].<ref>[http://www.who.is/whois/aspartame-info.com/ REGISTRY WHOIS FOR ASPARTAME-INFO.COM], WhoIs?, accessed 23 March 2010. Screengrab [http://www.spinprofiles.org/index.php/Image:Aspartamewhois.jpg here]</ref> | In 2000 it set up a website, [[Aspartame Information]] (http://www.aspartame-info.com), to give information to the public about the controversial artificial sweetener [[aspartame]].<ref>[http://www.who.is/whois/aspartame-info.com/ REGISTRY WHOIS FOR ASPARTAME-INFO.COM], WhoIs?, accessed 23 March 2010. Screengrab [http://www.spinprofiles.org/index.php/Image:Aspartamewhois.jpg here]</ref> | ||
| − | In 2009 [[Ailbhe Fallon]], managing director of Fallon-Currie, who described herself as a spokesperson for Aspartame Information, told FoodNavigator.com that a reassurance about the safety of aspartame from the [[EFSA]] "came as no surprise".<ref>Sarah Hills, [http://www.foodnavigator.com/Financial-Industry/EFSA-finds-no-reason-to-alter-aspartame-ADI EFSA finds no reason to alter aspartame ADI], FoodNavigator.com, 22-Apr-2009, accessed 23 Mar 2010</ref> EFSA's assurance came in response to a study by the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation (ERF) published in June 2007 by Soffritti et al. The study's authors concluded that their results confirmed and reinforced their first experimental demonstration of aspartame’s multipotential carcinogenicity at a dose level close to the human ADI (actual daily intake). They also suggested that carcinogenic effects are increased when lifespan exposure to aspartame begins during foetal life. | + | In 2009 [[Ailbhe Fallon]], managing director of Fallon-Currie, who described herself as a spokesperson for Aspartame Information, told FoodNavigator.com that a reassurance about the safety of aspartame from the [[EFSA]] "came as no surprise".<ref>Sarah Hills, [http://www.foodnavigator.com/Financial-Industry/EFSA-finds-no-reason-to-alter-aspartame-ADI EFSA finds no reason to alter aspartame ADI], FoodNavigator.com, 22-Apr-2009, accessed 23 Mar 2010</ref> EFSA's assurance came in response to a study by the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation (ERF) published in June 2007 by Soffritti et al. The study's authors concluded that their results confirmed and reinforced their first experimental demonstration of aspartame’s multipotential carcinogenicity at a dose level close to the human ADI (actual daily intake). They also suggested that carcinogenic effects are increased when lifespan exposure to aspartame begins during foetal life.<ref>Sarah Hills, [http://www.foodnavigator.com/Financial-Industry/EFSA-finds-no-reason-to-alter-aspartame-ADI EFSA finds no reason to alter aspartame ADI], FoodNavigator.com, 22-Apr-2009, accessed 23 Mar 2010</ref> |
===History=== | ===History=== | ||
Revision as of 15:27, 23 March 2010
|
This article is part of the Lobbying Portal, a sunlight project from Spinwatch. |
Fallon Currie Consulting is a PR/lobbying firm.
Contents
Reassuring the public about the safety of aspartame
In 2000 it set up a website, Aspartame Information (http://www.aspartame-info.com), to give information to the public about the controversial artificial sweetener aspartame.[1]
In 2009 Ailbhe Fallon, managing director of Fallon-Currie, who described herself as a spokesperson for Aspartame Information, told FoodNavigator.com that a reassurance about the safety of aspartame from the EFSA "came as no surprise".[2] EFSA's assurance came in response to a study by the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation (ERF) published in June 2007 by Soffritti et al. The study's authors concluded that their results confirmed and reinforced their first experimental demonstration of aspartame’s multipotential carcinogenicity at a dose level close to the human ADI (actual daily intake). They also suggested that carcinogenic effects are increased when lifespan exposure to aspartame begins during foetal life.[3]
History
Activities
Views
Affiliations
People
- Ailbhe Fallon, managing director[4]
Funding
Clients
Publications, Contact, Resources and Notes
Publications
Contact
- Address:
- Phone:
- Email:
- Website:
Resources
Notes
- ↑ REGISTRY WHOIS FOR ASPARTAME-INFO.COM, WhoIs?, accessed 23 March 2010. Screengrab here
- ↑ Sarah Hills, EFSA finds no reason to alter aspartame ADI, FoodNavigator.com, 22-Apr-2009, accessed 23 Mar 2010
- ↑ Sarah Hills, EFSA finds no reason to alter aspartame ADI, FoodNavigator.com, 22-Apr-2009, accessed 23 Mar 2010
- ↑ Sarah Hills, EFSA finds no reason to alter aspartame ADI, FoodNavigator.com, 22-Apr-2009, accessed 23 Mar 2010
